Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01587703
Title A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

lung non-small cell carcinoma

neuroblastoma

lung small cell carcinoma

colorectal cancer

triple-receptor negative breast cancer

multiple myeloma

NUT midline carcinoma

prostate cancer

estrogen-receptor positive breast cancer

Advanced Solid Tumor

Therapies

Molibresib

Age Groups: adult | senior | child
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
GSK Investigational Site Baltimore Maryland 21231-2410 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104 United States Details
GSK Investigational Site Nashville Tennessee 37232 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Clayton Victoria 3168 Australia Details
GSK Investigational Site Bordeaux Cedex 33076 France Details
GSK Investigational Site Lyon Cedex 08 69373 France Details
GSK Investigational Site Paris Cedex 5 75248 France Details
GSK Investigational Site Seoul 03080 Korea, Republic of Details
GSK Investigational Site Seoul 03722 Korea, Republic of Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Sutton Surrey SM2 5PT United Kingdom Details
GSK Investigational Site Newcastle upon Tyne NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field